506 related articles for article (PubMed ID: 21242734)
1. Suprathel-antiseptic matrix: in vitro model for local antiseptic treatment?
Ryssel H; Andreas Radu C; Germann G; Kloeters O; Riedel K; Otte M; Kremer T
Adv Skin Wound Care; 2011 Feb; 24(2):64-7. PubMed ID: 21242734
[TBL] [Abstract][Full Text] [Related]
2. The antimicrobial effect of acetic acid--an alternative to common local antiseptics?
Ryssel H; Kloeters O; Germann G; Schäfer T; Wiedemann G; Oehlbauer M
Burns; 2009 Aug; 35(5):695-700. PubMed ID: 19286325
[TBL] [Abstract][Full Text] [Related]
3. Suprathel-acetic acid matrix versus acticoat and aquacel as an antiseptic dressing: an in vitro study.
Ryssel H; Germann G; Riedel K; Reichenberger M; Hellmich S; Kloeters O
Ann Plast Surg; 2010 Oct; 65(4):391-5. PubMed ID: 20798627
[TBL] [Abstract][Full Text] [Related]
4. Antiseptic therapy with a polylacticacid-acetic acid matrix in burns.
Ryssel H; Gazyakan E; Germann G; Hellmich S; Riedel K; Reichenberger MA; Radu CA
Wound Repair Regen; 2010; 18(5):439-44. PubMed ID: 20731796
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of multidrug-resistant organisms recovered at a military burn center.
Keen EF; Robinson BJ; Hospenthal DR; Aldous WK; Wolf SE; Chung KK; Murray CK
Burns; 2010 Sep; 36(6):819-25. PubMed ID: 20080354
[TBL] [Abstract][Full Text] [Related]
6. Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate.
Koburger T; Hübner NO; Braun M; Siebert J; Kramer A
J Antimicrob Chemother; 2010 Aug; 65(8):1712-9. PubMed ID: 20551215
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT
J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance analysis of bacterial strains isolated from burn patients.
Wang LF; Li JL; Ma WH; Li JY
Genet Mol Res; 2014 Jan; 13(4):9727-34. PubMed ID: 24535909
[TBL] [Abstract][Full Text] [Related]
9. Cationic compounds with activity against multidrug-resistant bacteria: interest of a new compound compared with two older antiseptics, hexamidine and chlorhexidine.
Grare M; Dibama HM; Lafosse S; Ribon A; Mourer M; Regnouf-de-Vains JB; Finance C; Duval RE
Clin Microbiol Infect; 2010 May; 16(5):432-8. PubMed ID: 19456831
[TBL] [Abstract][Full Text] [Related]
10. Dimers of nostocarboline with potent antibacterial activity.
Locher HH; Ritz D; Pfaff P; Gaertner M; Knezevic A; Sabato D; Schroeder S; Barbaras D; Gademann K
Chemotherapy; 2010; 56(4):318-24. PubMed ID: 20714150
[TBL] [Abstract][Full Text] [Related]
11. In vitro efficacy of various topical antimicrobial agents in different time periods from contamination to application against 6 multidrug-resistant bacterial strains isolated from burn patients.
Hajská M; Slobodníková L; Hupková H; Koller J
Burns; 2014 Jun; 40(4):713-8. PubMed ID: 24091332
[TBL] [Abstract][Full Text] [Related]
12. Changes in bacterial isolates from burn wounds and their antibiograms: a 20-year study (1986-2005).
Guggenheim M; Zbinden R; Handschin AE; Gohritz A; Altintas MA; Giovanoli P
Burns; 2009 Jun; 35(4):553-60. PubMed ID: 19167827
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of tigecycline against resistant micro-organisms isolated from burn patients.
Timurkaynak F; Arslan H; Azap OK; Senger SS; Başaran O; Karaman SO; Haberal M
Burns; 2008 Nov; 34(7):1033-6. PubMed ID: 18539397
[TBL] [Abstract][Full Text] [Related]
14. Tigecycline: first of a new class of antimicrobial agents.
Rose WE; Rybak MJ
Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic resistance in clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus does not impact sensitivity to human beta defensin 4.
Supp DM; Gardner J; Klingenberg JM; Neely AN
Burns; 2009 Nov; 35(7):949-55. PubMed ID: 19501982
[TBL] [Abstract][Full Text] [Related]
17. In vitro bactericidal activity of human beta-defensin 2 against nosocomial strains.
Routsias JG; Karagounis P; Parvulesku G; Legakis NJ; Tsakris A
Peptides; 2010 Sep; 31(9):1654-60. PubMed ID: 20600430
[TBL] [Abstract][Full Text] [Related]
18. [Bacteriological surveillance in a burn intensive care unit and the analysis of bacterial resistance to antibiotics].
Chen L; Deng SL; Liang JW; Zhang YH; Liu JW
Zhonghua Shao Shang Za Zhi; 2005 Aug; 21(4):270-2. PubMed ID: 16185410
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a bi-layer wound dressing for burn care. II. In vitro and in vivo bactericidal properties.
Martineau L; Shek PN
Burns; 2006 Mar; 32(2):172-9. PubMed ID: 16455202
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Zürich burn-biofilm model.
Guggenheim M; Thurnheer T; Gmür R; Giovanoli P; Guggenheim B
Burns; 2011 Nov; 37(7):1125-33. PubMed ID: 21724333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
